Pharos Secures $5 Million in Seed Round
Pharos, a San Francisco, CA-based hospital quality reporting platform, has secured $5 million in seed funding.
The round was led by Felicis, with participation from General Catalyst, Moxxie, and Y Combinator.
Founded in 2006, Felicis is a Menlo Park, CA-based venture capital firm investing across industries and stages. Felicis supports founders in building iconic companies and has backed over 49 companies valued at $1 billion+, with 17 IPOs.
The company will use the new funding to expand its engineering team.
Founded by Felix Brann, Matthew Jones, and Dr. Alex Clarke, Pharos is a healthcare technology company that provides a hospital quality reporting platform. Using AI, Pharos automates clinical quality reporting for hospitals, enabling submission to state and national quality registries without manual data abstraction. Additionally, by allowing automatic extraction of custom process metrics, Pharos helps quality teams identify the process failures that are contributing to patient harm, enabling action on issues like sepsis mortality, hospital-acquired infections, and pressure ulcers.
Funding Details
Company: Pharos
Raised: $5.0M
Round: Seed
Funding Date: October 2024
Lead Investor: Felicis
Additional Investors: General Catalyst, Moxxie, Y Combinator
Company Website: https://pharos.health/
Software Category: Hospital Quality Reporting and Analytics